Profiel
Violetta Cotreau worked as the Chief Accounting Officer & Senior Vice President at Akebia Therapeutics, Inc. from 2020 to 2022.
Prior to that, she was the Senior Vice President & Controller at AMAG Pharmaceuticals, Inc. from 2016 to 2020.
She completed her undergraduate degree at the University of Massachusetts Lowell.
Eerdere bekende functies van Violetta Cotreau
| Bedrijven | Functie | Einde |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30-12-2022 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-11-2020 |
Opleiding van Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
